Imitarscience Overview
- Year Founded
-
2021
- Status
-
Private
- Employees
-
5
- Latest Deal Type
-
Accelerator/Inc
- Investors
-
5
Imitarscience General Information
Description
Developer of organ-on-a-chip technology designed for drug development and toxicity evaluation. The company offers a multi-organoid culture module chip, drug screening platform, toxicity evaluation tools, efficacy testing systems, biomimetic organ chips, and non-clinical research tools, enabling pharmaceutical companies and research institutions to evaluate active compounds through microchannel interconnection and fluid dynamics simulation.
Contact Information
Website
www.imitarscience.comCorporate Office
- Room 316, Insta 1, Incheon Startup Park, 204
- Conventionia-daero, Yeonsu-gu
- Incheon
- South Korea
Corporate Office
- Room 316, Insta 1, Incheon Startup Park, 204
- Conventionia-daero, Yeonsu-gu
- Incheon
- South Korea
Imitarscience Timeline
Imitarscience Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 7. Accelerator/Incubator | 04-Nov-2026 | Completed | Generating Revenue | |||
| 6. Seed Round | 23-Jul-2026 | Completed | Generating Revenue | |||
| 5. Accelerator/Incubator | 10-Jun-2026 | Completed | Generating Revenue | |||
| 4. Accelerator/Incubator | Completed | Generating Revenue | ||||
| 3. Accelerator/Incubator | 01-Aug-2022 | Completed | Generating Revenue | |||
| 2. Angel (individual) | 01-Mar-2022 | $167K | $167K | Completed | Generating Revenue | |
| 1. Accelerator/Incubator | 01-Dec-2021 | Completed | Generating Revenue |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
Imitarscience Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Imitarscience Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Imitarscience Investors (5)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Genaxis (Korea) | Venture Capital | Minority | ||
| Incheon Technology Partners | Venture Capital | Minority | ||
| Seoul Biohub | Accelerator/Incubator | |||
| Tipa(Korea Technology and Information Promotion Agency for SMEs) | Corporation | |||
| Incheon Startup Park | Accelerator/Incubator |
Imitarscience FAQs
-
When was Imitarscience founded?
Imitarscience was founded in 2021.
-
Where is Imitarscience headquartered?
Imitarscience is headquartered in Incheon, South Korea.
-
What is the size of Imitarscience?
Imitarscience has 5 total employees.
-
What industry is Imitarscience in?
Imitarscience’s primary industry is Discovery Tools (Healthcare).
-
Is Imitarscience a private or public company?
Imitarscience is a Private company.
-
What is Imitarscience’s current revenue?
The current revenue for Imitarscience is .
-
How much funding has Imitarscience raised over time?
Imitarscience has raised $299K.
-
Who are Imitarscience’s investors?
Genaxis (Korea), Incheon Technology Partners, Seoul Biohub, Tipa(Korea Technology and Information Promotion Agency for SMEs), and Incheon Startup Park have invested in Imitarscience.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
